Jumo Health Expands Health Equity Service Line
Expanded offerings will increase Black representation in clinical trials, ensuring that new medicines are safe and effective for people of color.
Jumo Health announced that, together with the I Choose Life Foundation (ICLF), it has expanded its health equity service line to include the recruitment and retention of people of color in clinical trials.
To guide their pharmaceutical and biotech customers as they endeavor to develop culturally responsible medications, Jumo Health and ICLF have amassed a national network of more than 2,000 churches that primarily serve Black congregations. Those 2,000 churches, which are located across the United States, have more than 500,000 members.
"Jumo Health explains difficult medical concepts in ways people can understand and act upon," stated Kevin Aniskovich, president and CEO of Jumo Health. "With a keen understanding of health literacy, how various communities consume information, and the importance of storytelling, we ensure that people can 'see themselves' in the information provided; critically important when serving communities that have been historically overlooked by government and industry," continued Aniskovich.
Reference
Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials. (2023, March 1). Cision PR Newswire.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Generative AI Transforms Clinical Study Report Development
September 16th 2025
- Operational Strategies That Strengthened the NIMBLE Trial Design
September 16th 2025